Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part V: The discovery of the statins and the end of the controversy
Open Access
- 1 July 2006
- journal article
- comment
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 47 (7), 1339-1351
- https://doi.org/10.1194/jlr.r600009-jlr200
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Treatment of High-Risk patients with ezetimibe plus simvastatin Co-Administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III Low-Density lipoprotein cholesterol goalsThe American Journal of Cardiology, 2004
- Optimal low-density lipoprotein is 50 to 70 mg/dl: Lower is better and physiologically normalJournal of the American College of Cardiology, 2004
- The Helsinki Heart Study: an 8.5‐year safety and mortality follow‐upJournal of Internal Medicine, 1994
- Chemistry, biochemistry, and pharmacology of HMG-CoA reductase inhibitorsJournal of Molecular Medicine, 1988
- Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial HypercholesterolemiaThe New England Journal of Medicine, 1981
- Effects of ML-236B on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animalsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
- Cholesterol, Coronaries, Clofibrate and DeathThe New England Journal of Medicine, 1978
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976
- Mechanism of action of MER-29, an inhibitor of cholesterol biosynthesisBiochemical and Biophysical Research Communications, 1960
- Failure of Alpha-Phenylbutyrate and Beta-Phenylvalerate in Treatment of HypercholesterolemiaCirculation, 1957